JENNIFER LAUX is a life sciences commercial executive, who has more than 20 years of leadership experience in marketing, new product planning, and strategic consulting. Her experience ranges from leading multi-billion dollar product franchises to developing initial commercialization plans for biotech start-ups. Ms. Laux joined Inovio in 2014 to lead development of the commercialization strategy for the company’s portfolio of oncology and infectious disease immunotherapies. Previously, Ms. Laux was Vice President of Cardiovascular Marketing at Boehringer Ingelheim. Prior to this, she held senior leadership positions at Merck & Co in marketing and market research for the Cardiovascular, Oncology, Biosimilar, and Women’s Health businesses. Her international experience includes marketing for Procter & Gamble in Brussels and Elizabeth Arden in Paris, as well as multiple consulting engagements with global clients at Bain & Company. Ms. Laux received an MBA in Marketing from the Wharton School, an MA in International Studies from the University of Pennsylvania, and a BA in International Relations and English from Georgetown University.

 oncology and infectious disease immunotherapies